Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 32199881.
- Also identified by DOI 10.1053/j.gastro.2020.02.059 and PMC identifier 7282937.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although the estimated time for development of pancreatic ductal adenocarcinoma (PDA) is more than 20 years, PDAs are usually detected at late, metastatic stages. PDAs develop from duct-like cells through a multistep carcinogenesis process, from low-grade dysplastic lesions to carcinoma in situ and eventually to metastatic disease. This process involves gradual acquisition of mutations in oncogenes and tumor suppressor genes, as well as changes in the pancreatic environment from a pro-inflammatory microenvironment that favors the development of early lesions, to a desmoplastic tumor microenvironment that is highly fibrotic and immune suppressive. This review discusses our current understanding of how PDA originates.
Medical subject headings
- Carcinoma, Pancreatic Ductal
- Cell Transformation, Neoplastic
- Pancreatic Neoplasms
- Tumor Microenvironment